Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
33.33
-0.38 (-1.13%)
At close: Apr 28, 2026, 4:00 PM EDT
34.38
+1.05 (3.15%)
After-hours: Apr 28, 2026, 6:30 PM EDT
Stoke Therapeutics Market Cap
Stoke Therapeutics has a market cap or net worth of $2.08 billion as of April 28, 2026. Its market cap has increased by 488.65% in one year.
Market Cap
2.08B
Enterprise Value
1.69B
1-Year Change
488.65%
Ranking
Category
Stock Price
$33.33
Market Cap Chart
Since June 19, 2019, Stoke Therapeutics's market cap has increased from $804.46M to $2.08B, an increase of 158.00%. That is a compound annual growth rate of 14.82%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sarepta Therapeutics | 2.21B |
| Adaptive Biotechnologies | 2.16B |
| Ascentage Pharma Group International | 2.16B |
| Mineralys Therapeutics | 2.13B |
| Definium Therapeutics | 2.12B |
| Tyra Biosciences | 2.09B |
| Aurinia Pharmaceuticals | 2.08B |
| Zymeworks | 2.06B |